0
Active Markets
2
Resolved
2
Total Tracked
Prediction accuracy: 50% hit rate, Brier 0.183
Based on 2 resolved markets
No active prediction markets for CRISPR Therapeutics at this time.
CRISPR Therapeutics (CRSP) is a major healthcare company operating in the Healthcare sector. Healthcare companies attract prediction market interest due to drug approvals, clinical trial outcomes, and regulatory decisions.
0
Active Markets
2
Resolved Markets
2
Total Tracked
With only 2 resolved markets, there isn't enough data yet to draw strong conclusions about prediction accuracy.
The Brier score measures how close predictions were to actual outcomes (lower is better, 0 is perfect). The hit rate shows how often the market's favored outcome actually occurred.
While there are no active prediction markets for CRISPR Therapeutics at this time, our platform has tracked 2 resolved markets historically. New markets may open around earnings announcements, product launches, or other significant corporate events.
No active markets for CRISPR Therapeutics at this time.
CRISPR Therapeutics (CRSP) is tracked across multiple prediction markets in the Healthcare sector. Our platform aggregates market data from Polymarket and Kalshi to provide real-time probability estimates for CRISPR Therapeutics-related events including earnings outcomes, stock price targets, and corporate milestones.